Trial Profile
Evaluation of systemic exposure between two nasal spray formulations of mometasone furoate in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Nov 2013
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Allergic rhinitis
- Focus Pharmacokinetics
- 14 Nov 2013 New trial record
- 08 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.